Marshall Wace LLP Cuts Position in Envista Holdings Co. (NYSE:NVST)

Marshall Wace LLP trimmed its stake in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 33.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 614,487 shares of the company's stock after selling 313,907 shares during the period. Marshall Wace LLP owned approximately 0.36% of Envista worth $11,853,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sterling Capital Management LLC grew its position in Envista by 53.9% during the fourth quarter. Sterling Capital Management LLC now owns 11,105 shares of the company's stock valued at $214,000 after buying an additional 3,888 shares during the period. Treasurer of the State of North Carolina lifted its position in shares of Envista by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock valued at $1,458,000 after buying an additional 480 shares in the last quarter. Bryce Point Capital LLC bought a new position in shares of Envista during the 4th quarter valued at approximately $590,000. Massachusetts Financial Services Co. MA raised its stake in Envista by 9.5% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,271,175 shares of the company's stock worth $63,101,000 after acquiring an additional 283,415 shares during the period. Finally, Trexquant Investment LP bought a new position in shares of Envista in the fourth quarter worth approximately $5,982,000.

Envista Trading Down 0.1 %

NYSE:NVST traded down $0.02 during mid-day trading on Friday, hitting $15.96. 2,273,467 shares of the stock traded hands, compared to its average volume of 2,503,464. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $2.75 billion, a price-to-earnings ratio of -2.46, a PEG ratio of 1.27 and a beta of 1.12. Envista Holdings Co. has a 52 week low of $14.22 and a 52 week high of $23.00. The firm's 50 day moving average is $17.22 and its two-hundred day moving average is $19.10.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities research analysts predict that Envista Holdings Co. will post 1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on NVST shares. UBS Group dropped their target price on shares of Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a report on Monday, March 10th. Piper Sandler lifted their target price on Envista from $17.00 to $18.00 and gave the company a "neutral" rating in a research note on Monday, February 3rd. Needham & Company LLC restated a "hold" rating on shares of Envista in a research note on Thursday, March 6th. New Street Research set a $19.00 target price on shares of Envista in a report on Thursday, March 6th. Finally, Jefferies Financial Group raised their target price on shares of Envista from $20.00 to $22.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Envista presently has a consensus rating of "Hold" and an average price target of $19.96.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.